If you have ever waited days for a prior authorization approval from your Medicare Advantage plan, or received a denial letter that seemed to ignore everything your doctor had documented, you are already living with the effects of artificial intelligence in health care. In 2026, AI is not a futuristic concept — it is embedded in the systems your Medicare Advantage plan uses every day to manage costs, coordinate care, and decide what gets covered. Understanding how it works, and where it can go wrong, is now essential knowledge for every Medicare beneficiary.
The scale of this shift is significant. According to CMS.gov data, approximately 33.8 million people were enrolled in Medicare Advantage plans as of 2024, representing more than half of all Medicare-eligible Americans. Every one of those enrollees now interacts — often without knowing it — with AI-driven systems that influence everything from which specialist referrals get approved to how chronic disease management programs are structured. The technology is moving faster than most beneficiaries realize, and in some cases faster than the regulatory guardrails designed to protect them.
The most visible place AI shows up in your Medicare Advantage plan is prior authorization — the process by which your plan decides whether to approve a procedure, medication, or specialist visit before you receive it. Many Medicare Advantage insurers now use AI algorithms to screen prior authorization requests, flagging some for automatic approval and routing others to human clinical reviewers. In theory, this speeds up routine approvals. In practice, patient advocates and civil rights organizations have raised documented concerns that some algorithms deny claims at higher rates for certain patient populations, and that automated denials frequently fail to account for the full clinical picture your physician has recorded.
CMS took direct aim at this problem with its 2024 final rule on Medicare Advantage prior authorization. That rule explicitly requires that coverage decisions — including those assisted or generated by AI — must be based on the individual patient's specific circumstances and must apply the same clinical criteria that would apply under traditional Medicare. The rule also shortened mandatory timelines: urgent prior authorization decisions must now be resolved within 72 hours, and standard decisions within 7 calendar days. If your Medicare Advantage plan denies a service, you have the right to appeal, and that right applies regardless of whether the denial was generated by an algorithm or a human reviewer. Your first step is always to request a written explanation of the denial, which the plan is legally required to provide.
The appeal process has four levels, and beneficiaries who pursue them with physician support have had meaningful success. The first level is a redetermination by the plan itself, which must be completed within 60 days for standard appeals or 72 hours for expedited appeals when your health is at immediate risk. If the plan upholds the denial, you can request reconsideration by a Qualified Independent Contractor — an outside reviewer with no financial relationship to your plan. If that review also goes against you, you can request a hearing before an Administrative Law Judge, provided the amount in dispute exceeds $180 (the 2024 threshold, adjusted annually). The final administrative level is review by the Medicare Appeals Council. At every stage, your physician's written documentation of medical necessity is your most powerful tool, and AI-generated denials have been overturned at significant rates when beneficiaries pursue appeals with that documentation in hand.
The deeper problem driving AI's uneven performance in Medicare Advantage is data fragmentation. When your cardiologist updates your medication list in one electronic health record system, your primary care physician is working in a different system, and your Medicare Advantage plan's care management team is working in a third system, the AI tools trying to coordinate your care are operating on incomplete information. This is not a hypothetical scenario — it is the daily reality for most Medicare beneficiaries with multiple chronic conditions. The algorithms are not necessarily wrong in their logic; they are working with data that is inconsistent, outdated, or siloed across incompatible platforms.
Seema Verma, the former CMS Administrator who now leads Oracle Health and Life Sciences as Executive Vice President and General Manager, has been vocal about this structural problem. Oracle Health is the second-largest electronic health records platform in the United States, with software installed in hospitals, physician offices, and health systems serving tens of millions of Medicare patients. Verma's argument — outlined in public discussions including a KFF health policy podcast — is that existing EHR infrastructure was never designed with AI in mind, and that a fundamental architectural redesign is necessary before AI can reliably improve care quality rather than simply automate existing inefficiencies. Oracle's redesign effort focuses on standardizing data formats, improving real-time interoperability between systems, and making clinical data accessible to AI tools in a consistent, structured way.
For a Medicare beneficiary managing diabetes, heart failure, and chronic kidney disease simultaneously, a well-integrated AI system could flag dangerous drug interactions before a prescription is filled, alert a care manager that recent lab values suggest a hospitalization risk, or remind the care team that a nephrology follow-up is overdue. These are genuinely valuable applications. The question is whether the infrastructure to support them reliably and equitably is in place — and whether the humans overseeing these systems are empowered and trained to override them when the algorithm gets it wrong.
Data Snapshot: According to CMS.gov data from the 2024 Medicare Advantage landscape file, beneficiaries had access to an average of 43 Medicare Advantage plan options per county in 2024, up from 39 options in 2023 and 33 options in 2021 — a 30 percent increase in plan availability over three years. The average Medicare Advantage plan premium in 2024 was approximately $18.50 per month, with a large share of plans continuing to offer $0 premium options. CMS star ratings data for 2024 showed that roughly 37 percent of Medicare Advantage enrollees were in plans rated 4 stars or higher, a metric that directly determines plan bonus payments and, by extension, the supplemental benefits plans can afford to offer. CMS has signaled that future star rating methodology revisions may incorporate measures related to prior authorization accuracy and AI-assisted care quality, which would create a direct financial incentive for plans to improve algorithmic performance.
For beneficiaries evaluating Medicare Advantage plans during the Annual Enrollment Period — which runs October 15 through December 7 each year, with coverage changes taking effect January 1 — the rise of AI in plan operations adds a practical layer of due diligence. When comparing plans on Medicare.gov's Plan Finder tool, look beyond premium and drug costs to examine prior authorization requirements and the plan's star rating on care coordination measures. You can also call a plan's member services line and ask directly whether automated or algorithmic tools are used in prior authorization screening, and what the plan's appeal overturn rate is. A licensed insurance broker or a State Health Insurance Assistance Program counselor — SHIP counselors are available in every state at no cost to you through shiphelp.org — can help you interpret this information and compare plans side by side.
The Open Enrollment Period, which runs January 1 through March 31 each year, gives beneficiaries who enrolled in a Medicare Advantage plan during AEP one additional opportunity to switch to a different Medicare Advantage plan or return to Original Medicare, with coverage changes effective the first day of the following month. If you have experienced repeated prior authorization denials or care coordination failures under your current plan — problems that may reflect algorithmic errors or data fragmentation — this window is your opportunity to make a change without waiting until the next AEP. Be aware, however, that switching back to Original Medicare during OEP does not automatically guarantee you a Medigap policy. In most states, insurers can apply medical underwriting outside of guaranteed issue periods, which means pre-existing conditions could affect your eligibility or premium. The exceptions are the birthday rule states, where you have a 30-day window around your birthday each year to switch Medigap plans without medical underwriting: California, Idaho, Illinois, Kentucky, Louisiana, Maine, Maryland, Missouri, Nevada, New Jersey, New York, Oklahoma, and Oregon.
Congress has been paying attention to the AI-in-Medicare-Advantage issue. Multiple hearings in 2025 and into 2026 have examined how plans use algorithms in coverage decisions, with particular scrutiny on whether AI tools have been used to systematically deny care to beneficiaries who would have been approved under traditional Medicare criteria. CMS has responded by increasing audit activity around prior authorization practices and by strengthening the requirement that plans document the clinical basis for every denial — a requirement that applies equally to AI-generated and human-generated decisions.
The integration of AI into Medicare Advantage is not going to slow down. As EHR platforms complete interoperability redesigns and as CMS continues pushing data-sharing mandates under the 21st Century Cures Act, the volume of clinical data flowing into AI systems will increase substantially. That creates both opportunity and risk. The opportunity is genuinely better care coordination for beneficiaries with complex conditions. The risk is that faster, more automated decision-making — if not properly overseen — produces faster, more automated errors.
The most actionable protection available to you right now is documentation. Keep a personal record of every prior authorization request you submit, every denial you receive, and every appeal you file. When a denial arrives, request the specific clinical criteria the plan applied — you are entitled to this in writing. Ask your physician to respond to those criteria directly in a letter of medical necessity. Use your SHIP counselor to evaluate whether your current plan's track record on prior authorization and care coordination holds up to scrutiny before the next enrollment window closes. The machine is being rewired. Making sure it is rewired in your favor starts with knowing exactly how it works.